Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-25
1999-02-02
Huang, Evelyn
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142278, 5142355, 514252, 514316, 514326, 514330, 540597, 544100, 544130, 544360, 544391, 546188, 546189, 546205, 546208, 546209, 546214, 546226, A61K 31445, A61K 31395, A61K 31535, C07D21132
Patent
active
058665927
ABSTRACT:
Compounds of the following general formula (I) and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 5430024 (1995-07-01), Alig et al.
PCT International Preliminary Examination Report, PCT/JP 95/02763, 1997.
Asari Tohru
Harada Takeo
Hayashi Yoshio
Katada Jun
Miyazaki Hiroshi
Huang Evelyn
Nippon Steel Chemical Co. Ltd.
Nippon Steel Corporation
LandOfFree
Fibrinogen receptor antagonist and pharmaceutical compositions c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonist and pharmaceutical compositions c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonist and pharmaceutical compositions c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1117823